Identifying the molecular mechanisms that control differential gene expression (DE) is a major goal of basic and disease 7 biology. Combining the strengths of systems biology and deep learning in a model called DEcode, we are able to predict 8 DE more accurately than traditional sequence-based methods, which do not utilize systems biology data. To determine 9 the biological origins of this accuracy, we identify the most predictive regulators and types of regulatory interactions in 10 DEcode, contrasting their roles across many human tissues. Diverse systems biology, ontological and disease-related 11 assessments all point to the predominant influence of post-translational RNA-binding factors on DE. Through the 12 combinatorial gene regulation that is captured in DEcode, it is even possible to predict relatively subtle person-to-person 13 variation in gene expression. We demonstrate the broad applicability of these clinically-relevant predictions by predicting 14 drivers of aging throughout the human lifespan, gene coexpression relationships on a genome-wide scale, and frequent 15 DE in diverse conditions. Researchers can freely access DEcode to utilize genomic big data in identifying influential 16 molecular mechanisms for any human expression data -www.differentialexpression.org. 17 18 While all human cells share DNA sequences, gene regulation differs among cell types and developmental stages, and in 19 response to environmental cues and stimuli. Accordingly, when gene expression is not properly regulated, cellular 20 homeostasis can be perturbed, often affecting cell function and leading to disease 1 . These distinctions between cell 21 states are observed as differential expression (DE) of gene transcripts. DE have been cataloged for tens of thousands of 22 gene expression datasets, in the context of distinctions between species, organs, and conditions. Despite the important 23
Introduction and pervasive nature of DE, it has been challenging to shift from these observations towards a coherent understanding 24 of the underlying generative processes that would essentially decode DE-a transition which is essential for progress in 25 basic and disease biology. We address this gap by exploiting novel computational and systems biology approaches to 26 develop a predictive model of DE based on genome-wide regulatory interaction data. Utilizing diverse genomic 27 datasets, we identify a complex, yet strikingly consistent set of principles that control DE. This model of differential 28 expression, called DEcode, can be applied to the majority of current and future gene expression data, to accelerate basic 29 and disease biology, by identifying the origins of DE in each experiment. 30 Diverse molecular interactions have been shown to generate DE, and jointly regulate gene expression at the 31 transcriptional and post-transcriptional levels. Major classes of gene regulatory interactions have been cataloged at the 32 genomic scale, including transcription factor (TF)-promoter interactions 2 , protein-RNA interactions 3 , RNA-RNA 33 interactions 4 , chromatin interactions 5 , and epigenetic modifications on DNAs 6 , histones, and RNAs 7 . Statistical models 34 of gene expression can help fulfill the purpose of these resources in describing the origins of gene regulation and DE 1 
. 35
However, such raw data resources have outpaced model development, likely due to the challenge of uniting diverse 36 molecular data into a single accurate model. 37
Predicting DE on the basis of gene regulatory interactions is one initial approach to understanding its origins. Among 38 many possible statistical approaches to predicting DE, deep learning (DL) blends diverse data sources in a way that 39 approximates the convergence of regulatory interactions. Indeed, DL has been applied to genomic research 8, 9 including 40 RNA splicing 10 , genomic variant functions 11 , and RNA/DNA binding 12 . However, accurate prediction is only one 41 component of understanding DE; additional genomic and systems biology analysis are helpful in understanding how 42 predictions are fueled by existing molecular concepts, mechanisms, and classes. 43
To decode the basis of DE in terms of molecular regulatory interactions, we first learn to predict it with a high degree of 44 accuracy, using a DL model we call "DEcode". This model combines several types of gene regulatory interactions and 45 allows us to prioritize the main systems and molecules that influence DE on a tissue-specific basis. We further establish 46 likely molecular mechanisms for this gene regulation and validate the influence of the predicted strongest regulators. In 47 parallel, we predict the origin of person-to-person DE, which is the major component of experimental and clinical studies. 48 predict gene expression in the 53 tissues. In this comparison, DEcode showed an average of 7.2% improvement in root 79 mean square error over ExPecto (Figure 2D) which translates into an average correlation coefficient with actual gene 80 expression of 0.42 -a 50% increase over 0.28 from ExPecto (Figure S2) . 81
Beyond the predictive performance of DEcode, we utilize the model to help define the biological processes regulating 82 DE. Many studies have demonstrated that TFs-promoter interactions are critical determinants of transcriptional activity 83 of promoter and thereby define gene expression levels 2 . However, it is unclear to what extent RNA features, which we 84 define as each RNA's binding sites of proteins and miRNA's, contribute to gene expression levels compared to TFs-85 promoter interactions. To answer this question, we re-trained the deep learning model, randomizing either RNA features, 86 promoter features, or both. We found that RNA features alone explained the actual TPM values better than the model 87 trained with promoter features (Figure 2E ). An example of how RNA features may distinguish between transcripts to a 88 greater extent than promotor features can be seen in the structure of the gene ACADM (Figure 2F) , which showed 89 substantial differences between the promoter-based model and the RNA-based model. For instance, the promoter-based 90 model could not distinguish 8 out of 11 transcripts coding for the ACADM gene that shared the same promoter region 91 (p1 in Figure 2F ). However, the actual expression levels for the 8 transcripts varied depending on the mRNA structures 92 and therefore were more accurately captured by the RNA-based model (Figure 2F) . However, the importance of RNA 93 features was tissue-dependent ( Figure 2G) , as gene expression in the aorta and coronary arteries were mainly defined by 94 TF-promoter interactions, whereas RNA-binding features were the major predictors for thyroid-specific or skeletal 95 muscle-specific expression. 96 97 Regulatory factors for differential expression across human tissues 98
To quantify the importance of the biological interactions weighted in the DEcode models, we calculated DeepLIFT 99 scores, which are a measure of the additive contribution of its binding site to each prediction 14, 15 and then averaged the 100
DeepLIFT scores for each interactor across genes (Table S2 ). Because DeepLIFT scores for the gene-based model and 101
the transcript-based model were well correlated (Spearman's rho = 0.52, P < 2.2e-16) (Figure S3 ), we focused on 102
DeepLIFT scores for the gene-based model in the following analyses. For the prediction of median TPM levels, the 103 enrichment of the binding sites of RNABPs peaked among the top 12% of influential predictors, which was significantly 104 greater than the influence of TFs and miRNAs (P < 0.00001) ( Figure 3A) . Indeed, out of the top 30 key predictors, 19 105 were RNABP's binding sites and 11 were TF binding sites. The direction of DeepLIFT scores indicates either a positive 106 binding sites of a given regulator reflect the differential activities of regulators across tissues. We hypothesized that the 114 differential activities of a regulator could be in part explained by the relative abundance of a regulator across tissues. 115
Based on this hypothesis, we contrasted DeepLIFT scores for the binding sites of each regulatory factor and its expression 116 levels across tissues. We indeed found that 99 RNABPs and 410 TFs showed significant correlations between DeepLIFT 117 scores of their binding sites and their expression levels (FDR < 5%) ( Figure S4) . These relationships were not based on 118 differences in expression profiles between brain and non-brain tissues, as the relationships remained the same without 119 brain tissues (Figure S5) . The sign of the correlation possibly reflects whether the binding of a regulator to RNA 120 increased or decreased the abundance of the RNA. For instance, the model suggested that PPARG and PTBP1 are positive 121 regulators of gene expression as DeepLIFT scores of PPARG or PTBP1 binding sites were higher in the tissues expressing 122 PPARG or PTBP1 at higher levels ( Figure 3D) . Indeed, PPARG is a transcriptional activator 20 and PTBP1 is a stabilizer 123 of RNAs 21 . Conversely, the expression levels of REST, a transcriptional repressor 16 , or METTL14, an RNA 124 methyltransferase destabilizing RNAs 22 , showed inverse correlations with their DeepLIFT scores as expected ( Figure  125 6 study and 601 genes were reported as being intolerant of homozygous or heterozygous LoF mutations, with probability 135 greater than 99%. We found that these LoF-mutation-intolerant regulators had greater DeepLIFT score magnitudes for 136 the prediction of the absolute gene expression ( Figure 3E and Table S3 ). In particular, these associations are based on 137 genes that are intolerant to both heterozygous and homozygous LoF mutations (Figure S6 ). This suggested that having 138 LoF mutations only in a single allele of the predicted critical regulators would cause a deleterious consequence on survival 139 or reproduction in humans. Next, to examine whether the predicted critical regulators of transcriptome indeed cause 140 diseases, we obtained disease-causing genes registered in the Online Mendelian Inheritance in Man (OMIM) 24 . We 141 confirmed that mutations in the regulators with high DeepLIFT scores tended to cause genetic disorders ( Figure 3E) . 142
Interestingly, their roles on fitness are likely preserved across species, as dysfunctions of the predicted critical regulators 143 also led pre-weaning lethality in mice ( Figure 3E) . Lastly, we asked whether the loss-of-function of the predicted critical 144 regulators of the transcriptome could also impair cellular viability, by overlapping them with loss-of-function screens for 145 a range of cellular models, from the Cancer Dependency Map project (DepMap) 31 . We found that the key genes for 146 cellular viability tended to have higher DeepLIFT scores in the DEcode model ( Figure 3E) . These results were robust, 147 as they were also supported by the DeepLIFT scores for the transcript-level model (Figure S7) . Together, the results 148 indicated that the critical predictors of transcriptome indeed play critical roles in maintaining vital cellular and body 149 functions. Thus the DEcode model can identify disease-causing genes, and this capability points toward the broader 150 validity of predicted key regulators. 151 152
DEcode predicts differential expression across individuals 153
Next, we asked whether the same input of promoter and RNA features could also predict relative expression differences 154 across individuals within the same tissue. We hypothesized that each individual has different activation levels of 155 regulatory factors, and thus those differences lead to person-specific differential expression of their targets. To verify our 156 hypothesis, we extended the DEcode framework to model differential expression across individuals for 14 representative 157 tissues with a sample size greater than 100 in GTEX. This was challenging as the average variance in gene expression 158 within tissues was less than 25% of that between tissues ( Figure S8 ). 159 7 correlation of ~0.28 ( Figure 4A) . The performance was further increased to 0.34 when we filtered out the models that 163 worked poorly for the validation data ( Figure S10 ). Note the model selection was performed based on validation data 164 alone, and all the follow-up performance evaluations and analyses were conducted by using testing data to prevent 165 information leaks that could inflate model performance (Figure S9) . The models were indeed person-specific as they did 166 not predict gene expression profiles of unrelated individuals (Figure 4A) . To examine if the model captured the person-167 specific expression shared across tissues 25 , we compared expression between tissues within the same individuals and 168 between different individuals. The predicted expression showed better concordance between tissues from the same 169 individuals, as is the case with actual expression data, which indicated the model captured the person-specific regulatory 170 mechanisms, even though we did not use any direct information that could identify individuals ( Figure 4B) . 171
Next, to gauge the contribution of RNA and promoter features to the person-specific expression profiles, we re-trained 172 models with randomized RNA features, promoter features, or both. The RNA-feature-based model performed on average 173 85% as well as the model trained with all features. This corresponded to an average 173% performance gain, compared 174 to the promoter-feature-based model, which suggested that the post-transcriptional controls are the major determinants 175 of the differential expression across individuals ( Figure 4C) . The model also allowed us to investigate the person-specific 176 activities of regulators by calculating DeepLIFT scores (Figure 4D) . At least 100 of regulators out of 933 regulators in 177 each tissue showed a good correlation between their DeepLIFT scores and expression levels across individuals (Figure 178 S11). The signs of these correlations were consistent between tissues, and consistent with those of the cross-tissue model 179 ( Figure S12 ). This suggested that differential expression between individuals and between tissues can be modeled by the 180 universal relationships between regulators and their targets. 181
To examine whether specific genes contributed to the per-person accuracy of the predicted gene expression, we also 182 assessed its accuracy on a per-gene basis. The predicted expression of a majority of the testing genes (78% on average) 183 showed significant positive correlations with the actual gene expression (FDR<5%). In order to assess whether this 184 predictive performance outperformed a state of the art method, we compared DEcode with PrediXcan 26 , which predicts 185 person-specific gene expression from genetic variations in cis-regulatory regions of genes. We built PrediXcan models 186 for each of the testing genes based on the same GTEX gene expression data used for the DEcode models and whole-187 genome sequence data of corresponding individuals (see Methods). The PrediXcan model predicted gene expression This suggested that the differential activity of transcriptional and post-transcriptional regulators has a larger effect on 190 gene expression than genetic variations in cis-regulatory regions. 191
The genes that DEcode could predict well were similar across tissues ( Figure S13 ). This suggested that the predictability 192 of gene expression is defined by gene characteristics rather than a target tissue. We, therefore, explored gene 193 characteristics that were associated with the per-gene accuracy of the predicted expression. We found that the models 194 showed higher performance for the genes that are registered in multiple gene annotation databases than those found only 195 in the GENCODE database ( Figure S14 ). The GENCODE-specific genes are novel or putative and thus their annotations 196 are not well established. Since both actual gene expression and binding features in RNA and promoter regions are likely 197 to be less accurate for such a novel or putative gene, it is reasonable that the performance of the model for those genes 198 was lower than other well-established genes. Beyond the annotation reliability, we found that the number of known 199 binding features for each gene had a larger effect on the predictability (Figure S15 ). This suggested that the more 200 information on RNA and promoter interactions is available, the more the prediction becomes accurate. Interestingly, the 201 number of binding features in RNAs was a stronger determinant of the predictive accuracy than that in promoter regions 202 ( Figure 4F and Figure S15 ). RNA-protein interactions are largely missing as global RNA-binding profiles are available 203 for only about 10% of known RNABPs 30 . Thus, the incompleteness of RNA features is likely to be an origin of lower 204 accuracy for a portion of genes. 205 206
DEcode predicts trait-related transcriptomic changes 207
Next, we asked whether the person-specific expression profiles predicted by the DEcode models also retained trait-208 associated differential expression changes. For this, we conducted differential expression analysis against the donor's 209 age and sex using the predicted gene expression data. Notably, test statistics of the predicted data showed significant 210 positive correlations with those of the actual data in all tissues for both traits (Figure 5A) . Especially, age-and sex-211 specific expression changes were well preserved in the predicted data in lung (Spearman's rho = 0.59, P < 2.2e-16) and 212 hippocampus (Spearman's rho = 0.47, P < 2.2e-16), respectively. The predicted associations were the closest to those of 213 corresponding tissues in 9 and 11 out of 14 tissues for age and sex, respectively ( Figure 5B ). This indicated that the 214 predicted gene expression changes against age and sex are tissue-specific in most cases, rather than the effects shared 9 904 in the breast mammary tissue, showed age-and sex-dependent changes at FDR 5%, respectively ( Figure 5C and 218 Table S4 ), which showed the capability of DEcode to associate transcriptional regulators with phenotypes. Although 219 there were more TFs associated with phenotypes than RNABPs and miRNAs, overall collective impacts of RNA features 220 on the generative process of DEs for age and sex were greater than those of promoter features in most tissues (Figure 221 S16). 222 223
DEcode predicts gene co-expression relationships 224
Co-expression analysis is a frequent component of transcriptome studies as gene-to-gene co-expression relationships are 225 regarded as functional units of the transcriptional system 27 . Therefore, we examined if the DEcode models could detect 226 known gene co-expression relationships. These tests were both a potential validation of the person-specific DEcode 227 predictions, and a means to explore the biological basis of co-expression. We found that the gene co-expression 228 relationships in the predicted gene expression profiles separated gene pairs with positive and negative correlation in the 229 actual gene expression data in each tissue ( Figure 6A) . Furthermore, the predicted gene expression profiles also detected 230 inter-tissue co-expression relationships (Figure 6B) . The accuracy of these results motivated us to investigate key factors 231 driving co-expression, via the DEcode predictions. RNA features alone could explain co-expression relationships better 232 than promoter features in most tissues (Figure 6C) , which again suggested the significant contribution of RNA features 233 to person-specific transcriptomes. 234
To further assess the capability of DEcode to decipher the mechanisms leading a specific co-expression relationship, we 235 focused on the co-expression of LAPTM5 and CD53, which were robustly co-expressed both in the simulated expression 236 data and the actual data in all tissues except whole-blood. Using the trained model, we simulated the consequences of 237 disruptions of promoter and mRNA features. The co-expression relationship was weakened when the features near 238 transcriptional start site (TSS) and 1,000 bp downstream of TSS in LAPTM5 or near TSS and 500 bp upstream of TSS in 239 CD53 were removed ( Figure 6D) . These observed effects were reasonable because many TFs bind to these regions 240 ( Figure 6D) . We further examined the specific regulators for the co-expression relationships by simulating knockout 241 (KO) effects of regulators. The in-silico KO experiments revealed that immune-related TFs such as SPI1 and TBX21 242 potentiated the co-expression relationships consistently across multiple tissues (Figure 6E) . To validate if these 243 regulators indeed induced the co-expression relationships, we conducted a mediation analysis that is an orthogonal 244 computational method to infer the effect of regulators on downstream targets. A mediation analysis evaluated the 245 hypothesis where if LAPTM5 and CD53 are co-expressed due to the predicted regulators, normalizing expression levels 246 of the two genes by the expression levels of the regulators would decrease the co-expression relationships. Specifically, 247 it quantified the covariance between LAPTM5 and CD53 explained by the expression levels of the predicted regulators 248 using the actual expression data. The set of the 10 regulators together mediated up to 94% of covariance, which was 249 significantly greater than the same number of randomly picked regulators (Figure 6F) . This example showed the utility 250 of DEcode framework to identify the drivers of the co-expression. 251 252
DEcode reveals molecular regulations for frequently DE genes in meta-transcriptomes 253
A recent meta-analysis of over 600 human transcriptome data revealed that some genes are more likely to be detected as 254 DE genes than others in diverse case-control studies 28 . From this observation, Megan et al. formulated the "DE prior", a 255 global ranking of gene's generic likelihood of being DE. The genes with high DE prior rank were significantly more 256 enriched with DE genes from a variety of conditions, as compared to other functional gene sets, such as those contained 257 in gene ontology or canonical pathways 28 . However, the regulatory-origin behind the ranking of these highly responsive 258
genes has yet to be uncovered. Therefore, we used DEcode to examine whether the DE prior rank could be generated by 259 gene regulatory interactions, and to identify critical regulatory relationships for frequently DE genes. The ability of 260 DEcode to predict global DE prior ranks was highly significant (P < 2.2e-16) and practically relevant (Spearman's rho = 261 0.53) ( Figure 7A ). Furthermore, DEcode was able to identify genes with high (90th percentile and greater) DE prior 262 probability (AUCROC = 0.81, 95% confidence interval = 0.78 -0.84) ( Figure 7B ). Re-training the model with 263 randomized inputs indicated that TF-promoter interactions were the major factors explaining the DE prior rank ( Figure  264 7B). To further characterize TFs that contributed to the prediction, we defined TFs with DeepLIFT score greater than 265 90th percentile as critical TFs (Table S5 ) and performed pathway analysis on them. We found that critical TFs were 266 enriched for cancer or inflammatory-related KEGG pathways (FDR<5%) such as pathways in cancer (Fold = 3.1, P = 267 4.2e-5), JAK-STAT signaling pathway (Fold = 6.8, P = 4.8e-5), chemokine signaling pathway (Fold = 7.3, P = 1.4e-4), 268 and acute myeloid leukemia (Fold = 4.5, P = 3.6e-4) ( Table S6 ). This result is consistent with the disease-related data 269 context for DE prior, which is 62% cancer-related and 23% inflammatory-related. Supported by the ability to predict DE 270 prior ranks, and by the consistency of these results, this application of DEcode illustrates how it goes beyond DE gene 271 lists, to uncover major key drivers for generating DE. 272
In summary, DEcode defines major principles in gene regulation in arbitrary gene expression data. It is applicable to 273 tracing the origins of complex gene expression patterns such as co-regulation, and also to arbitrary gene expression 274 signatures. This capacity is strongly supported on a comparative basis to alternative methods, and on an absolute basis 275 across diverse applications, which include, through predictions of transcript-usage, person-specific gene expression, 276 frequently DE genes of multiple external disease-related gene sets. 277
Discussion 278
We introduced the DEcode framework, which integrates a wealth of genomic data into a unified computational model of 279 transcriptome regulations to predict multiple transcriptional effects, including the absolute expression differences across 280 genes and transcripts, tissue-and person-specific transcriptomes. Systems biology analysis of these results provided 281 biological insights regarding the regulatory mechanisms of transcriptome. For instance, it suggested that absolute 282 expression levels are mainly under post-transcriptional control, whereas tissue-specific expression is shaped by both 283 transcriptional and post-transcriptional control. This implied that TFs act as a switch that initiates tissue-specific 284 transcriptional programs, but once a gene is transcribed at a certain level, its abundance in the cells will be primarily 285 regulated by RNABPs. The post-transcriptional regulators were also critical for explaining individual differences in 286 transcriptomes and thus may fine-tune the transcriptome in response to environmental and genetic factors. 287 Transcriptome analysis often identifies differentially expressed genes and then assesses the enrichment of functional 288 genes such as TF-targets one by one. The person-specific DEcode model offers several comparative advantages. First, 289
DEcode can take into account the effects of multiple regulators simultaneously as opposed to one at a time. Second, 290
DEcode can estimate the person-specific regulator's activities that can be used to identify regulators associated with a 291 phenotype of interest. Third, DEcode can simulate the consequence of KO perturbations for each gene. This step can 292 reduce the number of candidate key drivers of gene expression changes by an order of magnitude or more, and facilitates 293 the design of follow-up experiments. Therefore, DEcode can extract more actionable information from transcriptome 294 data, which will benefit a variety of transcriptome studies. 295
Looking toward even more expansive applications, the DEcode framework has the flexibility to incorporate other types 296 of genomic information such as DNA methylation, histone marks, and RNA modifications, and also can be extended to 297 other organisms. Thus, DEcode framework provides a direct bridge between accumulating genomic big data and 298 individual transcriptome studies, allowing researchers to predict molecules that control DE associated with any condition 299 or disease. 300
Materials and Methods

301
Transcriptome data processing 302 To prepare gene expression data used for the model training, we downloaded the median gene TPM from 53 human 303 tissues from the v7 release of GTEX portal (https://gtexportal.org). We kept 27,428 genes expressed greater than two 304 TPM in at least one tissue and log2-transformed TPM with the addition of 0.25 to avoid a negative infinity. Then, we 305 calculated the median log2-TPM across 53 tissues and log2-fold-changes relative to the median of all tissues. The 306 processed gene-level expression data comprised 27,428 genes with 54 columns including relative fold-changes for 53 307 tissues and the median log2-TPM across 53 tissues. To compile transcript-level data, we downloaded the individual-308 level transcript TPM from the GTEX portal and computed the median transcript TPM by tissue. We processed the 309 transcript data in the same way we did for the gene-level data. The resulted transcript-level data included 79,647 310 transcripts that corresponded to 23,813 genes. For building person-specific DEcode models, we obtained the gene-level 311 TPM for each individual in 14 tissues from the GTEX portal. We filtered out lowly-expressed genes in each tissue and 312 kept genes expressed greater than one TPM in at least 50% of samples. Then, we log2-transformed TPM with the 313 addition of 0.25 and then quantile normalized the log2-TPM. Finally, we removed the effects of technical covariates 314 including rRNA rate, intronic rate, and RIN number via linear regression for each gene followed by quantile 315 Then, we mapped the binding sites of RNABPs, miRNAs, and TFs to promoters and RNA-coding regions defined in 320 the GTF file provided by the GTEX portal. A promoter region of each gene was defined as the region from 2,000 bp 321 upstream of the transcriptional start site (TSS) to 1,000bp downstream of the TSS. We only used interactors that bind to 13 promoters or RNA-coding regions of at least 30 genes, or transcripts as the predictors in each model. To reduce the size 323 of the input, an RNA-coding region and a promoter region of each gene was binned with 100 bp intervals and the 324 number of bases bound to each RNABP, miRNA, or TF was counted in each interval. This step generated RNA and 325 DNA feature matrices for each gene described in Figure 1 . 326
Training tissue-specific models 327 For training the gene-level model of tissue-specific expression, we reserved all 2,705 genes coded on chromosome 1 as 328 the testing data and the rest of the genes was randomly split into training data (22,251 genes) and validation data (2,472 329 genes). In the case of the transcript model, we used all 7,631 transcripts coded on chromosome 1 as the testing data and 330 the rest of the transcripts was randomly split into training data (64,978 transcripts) and validation data (7,038 331 transcripts). The binding matrices were normalized by the maximum values for each binding protein and miRNA. The 332 relative fold-changes for 53 tissues were scaled together to set the standard deviation as one and the median log2-TPM 333 was separately scaled to set the standard deviation as one. These steps were conducted for the training data first and 334 then the same scaling factors were used for the validation and the testing data to avoid information leaking from those 335 data. We constructed and trained DL models using Keras (version 2.1.3) 32 with a TensorFlow (version 1.4.1) 33 336 backend. Hyper-parameters were optimized using hyperopt (version 0.2) 34 based on the mean squared error against the 337 validation data. The detailed structure of the model was described in Figure S17 . The training was done using mini-338 batches of 128 training examples with a learning rate of 0.001 for Adam optimizer 35 . The number of maximum training 339 epochs was set to 100 with early-stopping of 10 based on validation loss. This training cycle was repeated 10 times and 340 the best model for the validation data was selected as the final model ( Figure S1 ). All models were trained using 341 TITAN X Pascal graphics processing units (Nvidia). 342
Comparison of DEcode with ExPecto 343
To perform a fair comparison between DEcode and ExPecto 11 , we used 18,550 genes that were commonly included in 344 both studies and trained models with the same set of genes for training and evaluation. Since ExPecto model was 345 originally built using genes on chromosome 8 as the testing data, we followed the same procedure as we reserved all 346 the ExPecto repository (https://github.com/FunctionLab/ExPecto) as of Nov 2019. Given the epigenetic states, we built 349 a prediction model for tissue-specific gene expression for each tissue via XGBoost based on the training script 350 downloaded from the ExPecto repository. We modified the original script so that the early stopping of the model 351 optimization was decided based on the performance on the validation data instead of the testing data. This modification 352 prevented the overfitting of the model to the testing data. We used the same hyper-parameters for XGBoost as in the We calculated DeepLIFT scores for each gene in testing data for each of 54 outputs, then summed up the scores over 363 promoter or RNA regions for each feature, and finally averaged them over genes. 364
Disease genes 365
The probability that a gene is intolerant for a loss-of-function mutation was downloaded from the release 1.0 of the 366 ExAC portal (http://exac.broadinstitute.org). Disease genes were obtained from the OMIM portal as of June 2019 367 (https://www.omim.org/). We excluded provisional gene-to-phenotype associations and genes associated with non-368 disease phenotypes, multifactorial disorders, or infection. We obtained mouse-lethal genes from Gene Discovery 369 Informatics Toolkit (v1.0.0) 36 that provided pre-processed gene lists from the murine knock-out experiments registered 370 in Mouse genome informatics (MGI) 37 and the International Mouse Phenotyping Consortium (IMPC) 38 . The results of 371 CRISPR screening for the genes essential for proliferation or viability conducted in the DepMap project 39 were 372 downloaded from Enrichr portal 40, 41 as of June 2019 (https://amp.pharm.mssm.edu/Enrichr). Enrichr portal provided 373 two CRISPR screening results conducted independently at Broad Institute and the Sanger Institute. To reduce the false 374 positives in the CRISPR screening, we used essential genes that were identified in both of the two independent 375 screenings. 376
Training person-specific models 377 To train person-specific models, we utilized the same model structure as the tissue-model, except that the number of 378 model outputs was modified to match the sample size of the tissue. We re-used the parameters of convolutional layers 379
in the tissue-model and only parameters in the fully-connected layers were tuned (Figure S9) . We used the same gene 380 splits and the same procedure of normalization and scaling as the tissue-model for training and evaluating models. We 381 evaluated the model prediction for each individual separately based on validation data and filtered out the individual 382 models that performed less than 50% percentile of all individual models for some analyses (Figure S9) . 383
Training PrediXcan models 384
To build a prediction model for gene expression from genotype data, we trained PrediXcan 26 models with GTEX gene 385 expression and genotype data. A QCed vcf file of GTEx genotype data called by whole-genome sequence was 386 downloaded from dbGaP for 635 individuals. We filtered out variants with a missing rate greater than 1% and minor 387 allele frequency less than 1% and kept 9,219,660 variants for PrediXcan. We followed the model building procedure 388 employed in PredictDB (http://predictdb.org/), a repository of PrediXcan models, as of Nov 2019. Briefly, we 389 randomly split the samples into 5 folds. Then for each fold, we removed the fold from the data and used the remaining 390 data to train an elastic-net model using 10-fold cross-validation to tune the lambda parameter. With the trained model, 391
we predicted gene expression values for the hold out samples. We applied the PrediXcan method to predict the same 392 gene expression data used for the person-specific DEcode models. We built PrediXcan model for each gene using 393 variants located within 1 Mbp upstream and downstream of its TSS. A missing value of the genotype data was replaced 394 with an average dosage of non-missing samples. 395
Differential expression analysis for age and sex 396
Limma 42 was used to identify genes associated with age using gender as a covariate. The log2-TPM values of genes in 397 the testing data were used. We also tested the associations between DeepLIFT scores for predictors and age via limma 398 to identify regulators for DE against ages and sex. The Benjamini-Hochberg procedure was used to control the false 399 discovery rate at 5%. 400 in silico binding-site disruption experiment 401
To simulate the consequence of the removal of binding sites on the expression of LAPTM5 and CD53, we generated 402 10,000 synthetic inputs for each of LAPTM5 and CD53 where all binding sites in each interval of its promoter and 403 RNA were randomly removed. From each of these synthetic inputs, we computed predicted expression values and 404 correlated them with ones of another gene without any disruptions in its binding sites. Then, we used multiple linear 405 regression to associate the location of disrupted regions with the correlation values between LAPTM5 and CD53 to 406 estimate the effects of the disruption in each region on the co-expression relationship. 407 in silico knockout experiment 408
To simulate the effect of regulator knockout (KO) on the expression of LAPTM5 and CD53, we generated 10,000 409 synthetic inputs for each LAPTM5 and CD53 where each protein or miRNA bound to its promoter or RNA was 410 randomly removed from it feature matrices. From each of these synthetic inputs, we computed predicted expression 411 values and correlated them with ones of another gene without any removals in its feature matrices. Then, we used 412 multiple linear regression to associate KOs of regulators with the correlation values between LAPTM5 and CD53 to 413 estimate the effects of the KO of each regulator on the co-expression relationship. We applied the Bonferroni correction 414 to control multiple testing and the regulators with the corrected p-value less than 0.05 in all tissues were chosen as the 415 key drivers of the co-expression. 416
Conditional independence test 417
To validate the effect of the predicted drivers on co-expression, we conducted a conditional independence test. We 418 regressed the actual log2-TPM values of LAPTM5 and CD53 with the actual log2-TPM values of the predicted drivers 419 and computed R 2 (variance explained) between the residuals of two genes. The R 2 based on the actual gene expression 420 and one from the residuals were compared to quantify the covariance explained by the predicted drivers. To evaluate 421 the significance of this effect, we repeated this process 1,000 times with an equal number of randomly picked genes 422 that have a binding site in LAPTM5 or CD53 as regressors. 423
DEcode model for DE prior rank 424 DE prior rank was downloaded from https://github.com/maggiecrow/DEprior. In the DE prior rank, each gene has a 425 probability-like value where zero is the minimum and one is the maximum. To convert this value to a non-bounded 426 scale, we applied the logit transformation to the DE prior value. We assigned a value of 10 to a gene that had an infinite 427 value after the logit transformation. We used the same gene splits as the GTEX-tissue-model, which resulted in 13,433 428 genes for training, 1,504 genes for validation, and 1,674 genes for testing. We trained the DEcode model for DE prior 429 rank using the same procedure as with the GTEX-person-specific models. To evaluate the contribution of promoter and 430 RNA features to the prediction, the model was also trained with randomized input features. Receiver operating 431 characteristic (ROC) curve analysis was performed using pROC R package 43 with a default setting. We performed 432 pathway analysis of the TFs with a DeepLIFT score greater than 90th percentile using KEGG pathways 44 . KEGG 433 pathway gene sets were downloaded from MSigDB v6.1 45 . The enrichment significance was based on results of the 434 hypergeometric test, with 757 unique TF genes as a background, against KEGG pathways comprised of at least 5 435 background genes. FDR was controlled at 5%. We manually curated the 159 disease-related data sets used in the 436 construction of the DE prior ranking, to determine the number of data sets related to cancer or inflammatory disease. 437
Code and model availability 438
DEcode software and pre-trained models for tissue-and person-specific transcriptomes are available at 439 www.differentialexpression.org. 440
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